Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort.
Hernández-Conde M, Fernández I, Perelló C, Gallego A, Bonacci M, Pascasio JM, Romero-Gómez M, Llerena S, Fernández-Rodríguez C, Castro Urda JL, García Buey L, Carmona I, Morillas RM, García ND, Gea F, Carrión JA, Castellote J, Moreno-Planas JM, Piqueras Alcol B, Molina E, Diago M, Montoliu S, de la Vega J, Menéndez F, Sánchez Ruano JJ, García-Samaniego J, Rosales-Zabal JM, Anton MD, Badia E, Souto-Rodríguez R, Salmeron FJ, Fernández-Bermejo M, Figueruela B, Moreno-Palomares JJ, Calleja JL. Hernández-Conde M, et al. Among authors: de la vega j. J Viral Hepat. 2019 Jan;26(1):55-64. doi: 10.1111/jvh.13008. Epub 2018 Oct 25. J Viral Hepat. 2019. PMID: 30265418
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort.
Puigvehí M, De Cuenca B, Viu A, Diago M, Turnes J, Gea F, Pascasio JM, Lens S, Cabezas J, Badia E, Olveira A, Morillas RM, Torras X, Montoliu S, Cordero P, Castro JL, Salmerón J, Molina E, Sánchez-Ruano JJ, Moreno J, Antón MD, Moreno JM, De la Vega J, Calleja JL, Carrión JA. Puigvehí M, et al. Among authors: de cuenca b, de la vega j. Liver Int. 2019 Jan;39(1):90-97. doi: 10.1111/liv.13950. Epub 2018 Nov 12. Liver Int. 2019. PMID: 30160363
Optimisation in the multidisciplinary approach to patients with hepatitis C in the era of direct-acting antivirals.
Calleja JL, Bermúdez Á, Camacho Á, Cárdenas F, Fernández S, de Juan J, Jorquera F, Linares M, Rodríguez MÁ, Romero M, Ruiz JJ, José Sánchez M, de la Vega J. Calleja JL, et al. Among authors: de juan j, de la vega j. Gastroenterol Hepatol. 2019 Sep;42 Suppl 1:8-13. doi: 10.1016/S0210-5705(20)30182-5. Epub 2020 Jun 16. Gastroenterol Hepatol. 2019. PMID: 32560771 English, Spanish.
Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice.
Crespo J, Cabezas J, Sacristán B, Olcoz JL, Pérez R, De la Vega J, García R, García-Pajares F, Sáez-Royuela F, González JM, Jiménez F, Rodríguez S, Cuadrado A, López-Arias MJ, García I, Milla A, García-Riesco E, Muñoz M, Sánchez-Antolín G, Jorquera F. Crespo J, et al. Among authors: de la vega j. Liver Int. 2015 Feb;35(2):401-8. doi: 10.1111/liv.12536. Epub 2014 Apr 9. Liver Int. 2015. PMID: 24650000
Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome.
Vidal-Castiñeira JR, López-Vázquez A, Martínez-Borra J, Martínez-Camblor P, Prieto J, López-Rodríguez R, Sanz-Cameno P, de la Vega J, Rodrigo L, Pérez-López R, Pérez-Álvarez R, López-Larrea C. Vidal-Castiñeira JR, et al. Among authors: de la vega j. PLoS One. 2014 Jun 13;9(6):e99426. doi: 10.1371/journal.pone.0099426. eCollection 2014. PLoS One. 2014. PMID: 24927414 Free PMC article.
Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection.
Vidal-Castiñeira JR, López-Vázquez A, Diaz-Bulnes P, Díaz-Coto S, Márquez-Kisinousky L, Martínez-Borra J, Navascues CA, Sanz-Cameno P, de la Vega J, Astudillo A, Rodríguez M, López-Larrea C. Vidal-Castiñeira JR, et al. Among authors: de la vega j. J Mol Med (Berl). 2020 Sep;98(9):1245-1254. doi: 10.1007/s00109-020-01948-1. Epub 2020 Jul 9. J Mol Med (Berl). 2020. PMID: 32647953
Characteristics of ascitic fluid in ovarian carcinomatosis.
Sánchez-Lombraña JL, De la Vega J, Fernández E, Pérez R, Linares A, Rodríguez M, Rodrígo L. Sánchez-Lombraña JL, et al. Among authors: de la vega j. Rev Esp Enferm Dig. 1995 Feb;87(2):127-38. Rev Esp Enferm Dig. 1995. PMID: 7748705 English, Spanish. No abstract available.
69 results